Hrt Financial LP Biora Therapeutics, Inc. Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 10, 2023	BUY	$0.13 - $12.03 $7,183 - $664,729	55,256 Added 301.24%	73,599 $9,000
Q3 2022 Nov 14, 2022	SELL	$0.53 - $13.3 $3,537 - $88,777	-6,675 Reduced 26.68%	18,343 $8,000
Q2 2022 Aug 12, 2022	SELL	$0.56 - $1.22 $29,821 - $64,967	-53,252 Reduced 68.04%	25,018 $17,000
Q1 2022 May 16, 2022	BUY	$1.11 - $2.25 $86,879 - $176,107	78,270 New	78,270 $90,000
Q3 2021 Nov 15, 2021	SELL	$0.67 - $3.41 $26,199 - $133,344	-39,104 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.11 - $4.93 $76,179 - $177,992	-36,104 Reduced 48.01%	39,104 $139,000
Q1 2021 May 17, 2021	BUY	$3.91 - $7.31 $294,063 - $549,770	75,208 New	75,208 $357,000
Q4 2020 Feb 16, 2021	SELL	$3.27 - $9.48 $45,940 - $133,184	-14,049 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$7.71 - $10.79 $108,317 - $151,588	14,049 New	14,049 $126,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $41.1M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.